214 related articles for article (PubMed ID: 1454818)
1. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo.
Altar CA; Boylan CB; Jackson C; Hershenson S; Miller J; Wiegand SJ; Lindsay RM; Hyman C
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11347-51. PubMed ID: 1454818
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.
Altar CA; Boylan CB; Fritsche M; Jones BE; Jackson C; Wiegand SJ; Lindsay RM; Hyman C
J Neurochem; 1994 Sep; 63(3):1021-32. PubMed ID: 7519657
[TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine.
Martin-Iverson MT; Todd KG; Altar CA
J Neurosci; 1994 Mar; 14(3 Pt 1):1262-70. PubMed ID: 8074747
[TBL] [Abstract][Full Text] [Related]
4. The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra.
Altar CA; Boylan CB; Fritsche M; Jackson C; Hyman C; Lindsay RM
Exp Neurol; 1994 Nov; 130(1):31-40. PubMed ID: 7821394
[TBL] [Abstract][Full Text] [Related]
5. Effects of BDNF and NT-4/5 on striatonigral neuropeptides or nigral GABA neurons in vivo.
Arenas E; Akerud P; Wong V; Boylan C; Persson H; Lindsay RM; Altar CA
Eur J Neurosci; 1996 Aug; 8(8):1707-17. PubMed ID: 8921261
[TBL] [Abstract][Full Text] [Related]
6. Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts.
Sauer H; Fischer W; Nikkhah G; Wiegand SJ; Brundin P; Lindsay RM; Björklund A
Brain Res; 1993 Oct; 626(1-2):37-44. PubMed ID: 8281451
[TBL] [Abstract][Full Text] [Related]
7. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
Steranka LR
Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
[TBL] [Abstract][Full Text] [Related]
8. A single intramesencephalic injection of brain-derived neurotrophic factor induces persistent rotational asymmetry in rats.
Shults CW; Matthews RT; Altar CA; Hill LR; Langlais PJ
Exp Neurol; 1994 Feb; 125(2):183-94. PubMed ID: 8313937
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopamine neurons in vivo.
Shen RY; Altar CA; Chiodo LA
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8920-4. PubMed ID: 8090745
[TBL] [Abstract][Full Text] [Related]
10. The effect of a subchronic post-lesion treatment with (-)-deprenyl on the sensitivity of 6-OHDA-lesioned rats to apomorphine and d-amphetamine.
Spooren WP; Waldmeier P; Gentsch C
J Neural Transm (Vienna); 1999; 106(9-10):825-33. PubMed ID: 10599865
[TBL] [Abstract][Full Text] [Related]
11. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
Nicolaou NM
Eur J Pharmacol; 1980 Jun; 64(2-3):123-32. PubMed ID: 6105080
[TBL] [Abstract][Full Text] [Related]
12. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
Konieczny J; Lenda T; Czarnecka A
Neuroscience; 2016 Jun; 324():92-106. PubMed ID: 26964686
[TBL] [Abstract][Full Text] [Related]
13. Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats.
Kelly E; Jenner P; Marsden CD
J Pharm Pharmacol; 1987 Mar; 39(3):196-202. PubMed ID: 2883284
[TBL] [Abstract][Full Text] [Related]
14. Repeated developmental exposure to chlorpyrifos and methyl parathion causes persistent alterations in nicotinic acetylcholine subunit mRNA expression with chlorpyrifos altering dopamine metabolite levels.
Eells JB; Brown T
Neurotoxicol Teratol; 2009; 31(2):98-103. PubMed ID: 18977431
[TBL] [Abstract][Full Text] [Related]
15. Bilateral changes in striatal dopamine metabolism after unilateral intracarotid and intrastriatal administration of apomorphine.
Hyde JF; VanderWende C; Wood PL; Kim HF; Jerussi TP
Brain Res; 1994 Aug; 655(1-2):83-90. PubMed ID: 7812794
[TBL] [Abstract][Full Text] [Related]
16. Effects of apomorphine on in vivo release of dopamine and its metabolites in the prefrontal cortex and the striatum, studied by a microdialysis method.
Ozaki N; Nakahara D; Miura H; Kasahara Y; Nagatsu T
J Neurochem; 1989 Dec; 53(6):1861-4. PubMed ID: 2809596
[TBL] [Abstract][Full Text] [Related]
17. Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat.
Mufson EJ; Kroin JS; Sobreviela T; Burke MA; Kordower JH; Penn RD; Miller JA
Exp Neurol; 1994 Sep; 129(1):15-26. PubMed ID: 7523178
[TBL] [Abstract][Full Text] [Related]
18. Intranigral or intrastriatal injections of GDNF: effects on monoamine levels and behavior in rats.
Martin D; Miller G; Cullen T; Fischer N; Dix D; Russell D
Eur J Pharmacol; 1996 Dec; 317(2-3):247-56. PubMed ID: 8997607
[TBL] [Abstract][Full Text] [Related]
19. Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study.
Zetterström T; Sharp T; Ungerstedt U
Eur J Pharmacol; 1986 Dec; 132(1):1-9. PubMed ID: 3816961
[TBL] [Abstract][Full Text] [Related]
20. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
Nomura Y; Komori T; Okuda S; Segawa T
Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
